BeautyHealth Expects Q3 Net Sales Of $70M – $80M (Est $100.6M), FY24 Of $325M – $345M (Est $393.74M)
Portfolio Pulse from Benzinga Newsdesk
BeautyHealth has revised its Q3 net sales expectations to $70M – $80M, significantly below the estimated $100.6M. The company also adjusted its FY24 sales forecast to $325M – $345M, compared to the previous estimate of $393.74M. This is a notable downgrade from their earlier expectation of flat to low-single digit percentage growth.

August 08, 2024 | 9:36 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BeautyHealth has significantly downgraded its Q3 and FY24 sales expectations, which are now well below analyst estimates. This is likely to negatively impact the stock price in the short term.
The significant downgrade in sales expectations for both Q3 and FY24 is likely to lead to a negative market reaction. Investors typically react unfavorably to such revisions, especially when they are well below analyst estimates.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100